Here we present a report of a statistically significant association between the loss of GSTPi expression in breast cancer cells and the maintenance of its expression in vimentin/α-SMA-positive CAF in tumour microenvironment in paired cases of primary invasive breast cancer and corresponding axillary lymph node metastases. This evidence concerns the gene VIM and breast carcinoma.